Ventana wins one, loses one in patent rows
This article was originally published in Clinica
Ventana Medical Systems last week resolved a dispute with Vision Systems, a competitor in the tissue-based cancer diagnostics space, in which Ventana had accused the Melbourne, Australia-based firm of infringing a patent related to automated staining technologies.
You may also be interested in...
The latest drug development news and highlights from the Pink Sheet’s US FDA Performance Tracker.
US FDA’s latest effort to provide guidance for consumers on pharmacogenomics tests underscores the challenges the agency faces in the absence of a clear regulatory framework for lab-developed tests – and with no easy mechanism to update labels for off-patent drugs.